相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Increased Drp1 Acetylation by Lipid Overload Induces Cardiomyocyte Death and Heart Dysfunction
Hu Qingxun et al.
CIRCULATION RESEARCH (2020)
An implantable system for long-term assessment of atrial fibrillation substrate in unanesthetized rats exposed to underlying pathological conditions
Hadar Klapper-Goldstein et al.
SCIENTIFIC REPORTS (2020)
Impact of Sacubitril/Valsartan on Patient Outcomes in Heart Failure: Evidence to Date
Sara Akbar et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2020)
Degeneration of white matter and gray matter revealed by diffusion tensor imaging and pathological mechanism after spinal cord injury in canine
Chang-Bin Liu et al.
CNS NEUROSCIENCE & THERAPEUTICS (2019)
Sex-specific maternofetal innate immune responses triggered by group B Streptococci
Marie-Julie Allard et al.
SCIENTIFIC REPORTS (2019)
Rapid Atrial Pacing Promotes Atrial Fibrillation Substrate in Unanesthetized Instrumented Rats
Wesam Mulla et al.
FRONTIERS IN PHYSIOLOGY (2019)
Preserving Insulin Secretion in Diabetes by Inhibiting VDAC1 Overexpression and Surface Translocation in β Cells
Enming Zhang et al.
CELL METABOLISM (2019)
Resveratrol protects cardiomyocytes against anoxia/reoxygenation via dephosphorylation of VDAC1 by Akt-GSK3 β pathway
Mengyuan Tian et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Peroxynitrite nitrates adenine nucleotide translocase and voltage-dependent anion channel 1 and alters their interactions and association with hexokinase II in mitochondria
Meiying Yang et al.
MITOCHONDRION (2019)
VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease
Jeonghan Kim et al.
SCIENCE (2019)
WDR26/MIP2 interacts with VDAC1 and regulates VDAC1 expression levels in H9c2 cells
Lei Jiang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Intermittent hypoxia causes histological kidney damage and increases growth factor expression in a mouse model of obstructive sleep apnea
Bisher Abuyassin et al.
PLOS ONE (2018)
Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes
Dipak Kar et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Mitochondrial VDAC1 Silencing Leads to Metabolic Rewiring and the Reprogramming of Tumour Cells into Advanced Differentiated States
Tasleem Arif et al.
CANCERS (2018)
Mitochondria and cardiovascular diseases-from pathophysiology to treatment
Gerasimos Siasos et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
Heart failure with reduced ejection fraction
Michelle W. Bloom et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics
Varda Shoshan-Barmatz et al.
FRONTIERS IN ONCOLOGY (2017)
VDAC1 as a Player in Mitochondria-Mediated Apoptosis and Tar get for Modulating Apoptosis
Varda Shoshan-Barmatz et al.
CURRENT MEDICINAL CHEMISTRY (2017)
VDAC1 deacetylation is involved in the protective effects of resveratrol against mitochondria-mediated apoptosis in cardiomyocytes subjected to anoxia/reoxygenation injury
Zhihong Tong et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress
Varda Shoshan-Barmatz et al.
CELL STRESS (2017)
Mitochondrial involvement in myocyte death and heart failure
Michael J. Goldenthal
HEART FAILURE REVIEWS (2016)
Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction
Danya Ben-Hail et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
The novel heart-specific RING finger protein 207 is involved in energy metabolism in cardiomyocytes
Wataru Mizushima et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease
Robert G. Gourdie et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Heart Failure Complicating Acute Myocardial Infarction; Burden and Timing of Occurrence: A Nation-wide Analysis Including 86 771 Patients From the Cardiovascular Disease in Norway (CVDNOR) Project
Gerhard Sulo et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
lncRNA H19/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy
Xiangquan Li et al.
SCIENTIFIC REPORTS (2016)
The mitochondrial voltage-dependent anion channel 1 in tumor cells
Varda Shoshan-Barmatz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2015)
Cell Death in the Cardiac Myocyte
Tetsuro Marunouchi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Long-term oral resveratrol intake provides nutritional preconditioning against myocardial ischemia/reperfusion injury: Involvement of VDAC1 downregulation
Zhangping Liao et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2015)
The Renin-Angiotensin-Aldosterone System and Heart Failure
Gabriel Sayer et al.
CARDIOLOGY CLINICS (2014)
IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples
Frency Varghese et al.
PLOS ONE (2014)
Depressing Mitochondria-Reticulum Interactions Protects Cardiomyocytes From Lethal Hypoxia-Reoxygenation Injury
Melanie Paillard et al.
CIRCULATION (2013)
Apoptosis and angiogenesis: an evolving mechanism for fibrosis
Ariel Johnson et al.
FASEB JOURNAL (2013)
Mitochondrial dysfunction in heart failure
Mariana G. Rosca et al.
HEART FAILURE REVIEWS (2013)
Central roles of apoptotic proteins in mitochondrial function
S. M. Kilbride et al.
ONCOGENE (2013)
Role of α-crystallin B as a regulatory switch in modulating cardiomyocyte apoptosis by mitochondria or endoplasmic reticulum during cardiac hypertrophy and myocardial infarction
A. Mitra et al.
CELL DEATH & DISEASE (2013)
VDAC isoforms in mammals
Angela Messina et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2012)
Spironolactone Prevents Aldosterone Induced Increased Duration of Atrial Fibrillation in Rat
Carina Lammers et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2012)
Mitochondrial Control of Cellular Life, Stress, and Death
Lorenzo Galluzzi et al.
CIRCULATION RESEARCH (2012)
Aldosterone promotes atrial fibrillation
Jan-Christian Reil et al.
EUROPEAN HEART JOURNAL (2012)
VDAC, a multi-functional mitochondrial protein as a pharmacological target
Varda Shoshan-Barmatz et al.
MITOCHONDRION (2012)
Aldosterone Pathway in Atrial Fibrillation
Adam S. Budzikowski
CARDIOLOGY (2011)
Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation
Lixia Yue et al.
CARDIOVASCULAR RESEARCH (2011)
Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing
J. Zhao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Oligomerization of the Mitochondrial Protein Voltage-Dependent Anion Channel Is Coupled to the Induction of Apoptosis
Nurit Keinan et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Atrial fibrosis: Mechanisms and clinical relevance in atrial fibrillation
Brett Burstein et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Myocardial ischemia/reperfusion causes VDAC phosphorylation which is reduced by cardioprotection with a p38 MAP kinase inhibitor
Hansjorg Schwertz et al.
PROTEOMICS (2007)
Mechanisms of disease - The failing heart - An engine out of fuel
Stefan Neubauer
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Mitochondria: More than just a powerhouse
Heidi M. McBride et al.
CURRENT BIOLOGY (2006)
Subcellular localization of VDAC in mitochondria and ER in the cerebellum
V Shoshan-Barmatz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2004)
Role of apoptosis in remodeling after myocardial infarction
G Takemura et al.
PHARMACOLOGY & THERAPEUTICS (2004)
Apoptosis in myocardial ischaemia and infarction
PAJ Krijnen et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: Insight into the pathogenesis of phenotypes
DS Lim et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
分享论文
